ArticleMolecular therapy oncolytics2023

Pre-treatment with systemic agents for advanced NSCLC elicits changes in the phenotype of autologous T cell therapy products.

Charlotte O'Brien Gore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.